Bank Of America Corp Gilead Sciences, Inc. Call Options Transaction History

Bank Of America Corp

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $7.73 Million - $9.75 Million	-116,100 Reduced 26.24%	326,400 $27.4 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $6.34 Million - $7.32 Million	-100,400 Reduced 18.49%	442,500 $30.4 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $19.9 Million - $24.3 Million	278,300 Added 105.18%	542,900 $39.8 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $19.6 Million - $22.2 Million	-267,400 Reduced 50.26%	264,600 $21.4 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $5.89 Million - $6.72 Million	77,500 Added 17.05%	532,000 $41 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $15.5 Million - $17.7 Million	-200,700 Reduced 30.63%	454,500 $37.7 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $1.18 Million - $1.7 Million	19,000 Added 2.99%	655,200 $56.2 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $21 Million - $24 Million	353,400 Added 124.96%	636,200 $39.2 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $8.28 Million - $9.33 Million	-143,500 Reduced 33.66%	282,800 $17.5 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $68.6 Million - $86 Million	-1,184,900 Reduced 73.54%	426,300 $25.3 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $38.8 Million - $44 Million	597,900 Added 59.01%	1,611,200 $117 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $16.5 Million - $17.8 Million	-244,100 Reduced 19.41%	1,013,300 $70.8 Million
Q2 2021 Sep 13, 2021	BUY	$63.47 - $69.35 $79.8 Million - $87.2 Million	1,257,400 New	1,257,400 $86.6 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.